SEC61G and glioblastoma: In glioblastoma multiforme (GBM), Liu et al. demonstrated a significant correlation of high SEC61G expression with poor prognosis based on statistical analysis of sequencing data from the Cancer Genome Atlas cohort (TCGA) and the Chinese Glioma Genome Atlas cohort (CGGA) [337].